Amplatzer Amulet

For Complete
Occlusion of the
Left Atrial Appendage

Amplatzer Amulet LAA Occluder

As a stroke prevention device for patients with atrial fibrillation, the Amplatzer Amulet left atrial appendage (LAA) occluder is part of the industry-leading Amplatzer line of structural intervention occluders. The Amulet LAA Occluder is a part of Abbott’s broad structural heart portfolio.

Percutaneous, catheter-based occlusion of the LAA—the therapy provided by the Amplatzer Amulet LAA Occluder—is an increasingly performed procedure aiming to reduce the risk of stroke in patients with nonvalvular atrial fibrillation.1 Current evidence suggests that transcatheter occlusion of the LAA reduces the risk of thromboembolic complications associated with nonvalvular atrial fibrillation.2

  • David Hildick-Smith, MD
  • Reducing Stroke Risk
    David Hildick-Smith, MD, Royal Sussex County Hospital, Brighton, England

    “What this therapy [use of the Amplatzer Amulet LAA Occluder] does for the patient is twofold. One, it physically deals with the problem and reduces the risk of stroke very substantially. But more than that, it also offers patients a peace of mind.”

 


 

Animation Video:
AMPLATZER Amulet LAA Occluder

AP2947041-WBO Rev. A

References
  1. Landmesser U, et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. EuroIntervention. 2017;13:867-876.
  2. Lewalter T. An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. Europace. 2013; 15:652-656.
     

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.